about
American Cancer Society Colorectal Cancer Survivorship Care GuidelinesExercise Prevention of Cardiovascular Disease in Breast Cancer SurvivorsAutonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanismsCurrent Views on Anthracycline Cardiotoxicity in Childhood Cancer SurvivorsCardiac complications of chemotherapy: role of imaging.Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancerCardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future DirectionsRationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trRisk of hospitalization according to chemotherapy regimen in early-stage breast cancer.Present and future evolution of advanced breast cancer therapy.Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.Oral health after breast cancer treatment in postmenopausal women.Anthracycline cardiotoxicity: from bench to bedside.Cardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk.Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancerExtended adjuvant tamoxifen for early breast cancer: a meta-analysis.Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.Cardiovascular complications of breast cancer therapy in older adultsEvidence of altered autonomic cardiac regulation in breast cancer survivors.Myocardial ischemia in women: lessons from the NHLBI WISE study.Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.Influence of Adjuvant Therapy in Cancer Survivors on Endothelial Function and Skeletal Muscle Deoxygenation.Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - a prospective study.The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer.Doxorubicin-induced cardiomyopathy 17 years after chemotherapyCardiopulmonary function and age-related decline across the breast cancer survivorship continuumRationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention.Radiotherapy Induces Development of Fragmented QRS in Patients with Breast CancerBody Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.Neighborhood Disadvantage, Physical Activity Barriers, and Physical Activity among African American Breast Cancer SurvivorsPerformance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer.Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship.A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsCancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
P2860
Q26782671-207F1AEE-BE00-4124-9EBB-55E104D034BAQ26785410-347C2A0C-5E8A-42F1-8F6A-46790E0F0DECQ26795624-EFE8854F-2F8A-47D4-A2BE-A2CBF679DCE4Q28083073-11F130A7-CDBD-4EC3-9E1D-FB1FC093AAF9Q30415201-4F9F4645-E19D-4767-8290-BF44867B40C6Q30426853-81C1ED61-E7C4-4C81-9504-0E52C2AE02E7Q30446509-BF063C85-9AB9-43BF-9BA0-DE4877A470CAQ33711531-3D46BE08-2FC8-4304-8724-0521ADC754A0Q33907581-73CCCAF7-41E2-460A-AED3-70EA5230812EQ33973013-404D191F-172A-4483-BF17-5AE83FE43969Q34184798-B47881B4-B426-4863-AC48-787894C8D621Q34274925-830FA06A-8661-45FA-9598-CD541657C604Q34451772-C86968E6-BCD5-4315-BC3A-60F37A6AFC1CQ34457768-CFFA56F0-0FE0-4711-8FF7-F2DF03891274Q34477415-167D5F63-78EB-49E0-A7D6-E0EC25C8ECA8Q34998564-F9A3DA29-6A03-4F37-9FD7-CDFF3C497B8DQ35062498-970836A6-6922-412A-9688-46052EF7F4F7Q35106041-1787DAC3-8C39-463B-8446-D53105189638Q35158082-7D3B663D-3AAC-4EF8-834A-38989DF260B3Q35536301-85915EE6-68CE-4C40-9EA4-9DEC7AA0C833Q35584686-16FDC9B3-FF4D-43FB-88FC-D20AC67DC2BFQ35610969-6C572C76-B19D-411A-87EC-F4C742BE1FFFQ35816400-53E8AB24-5916-40AB-BF5C-96675CF73C54Q35878469-A072AD21-5503-4D41-B29D-800F51F41971Q35903018-A20527C5-6D3D-4874-8890-90523177A9C7Q35905883-EB74C7C2-DDCC-4C47-85C5-0FDF6090318AQ35990409-D51958F9-04BB-47D6-8441-425F35585C97Q36009452-C27FE330-9A54-42B6-AD0A-D9BD2E2260A0Q36011893-746FFB65-9215-4399-947D-3B8E0FF0C440Q36097712-6BC7CEC1-2996-41CD-9733-E830CFEE839AQ36133320-4050144C-D1A3-4D40-9786-218552CCC9EFQ36168700-31AD9508-CCB6-4A63-AA4F-BB5422CF6164Q36170686-7BEC6166-16D2-4B96-9A40-E1C9E7CE048BQ36212048-E2B63714-09D0-4612-8AD9-9A1364F9B1DBQ36262773-2A3E216C-186D-46E5-8C12-8D4FCBD45D6FQ36351160-3D0C3E8F-2F13-4EF8-B73B-9C7E42CC9402Q36457166-AEA7D765-1000-403F-9F77-7FE726BAD12AQ36544667-F5060860-D551-472C-90A4-A47420AF62BBQ36551901-D7CF98E5-05CA-4F58-89E4-3492834AD6DDQ36582822-8EC8D4A4-9565-48D7-8BFA-2C43AFE271C9
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Early breast cancer therapy and cardiovascular injury.
@en
type
label
Early breast cancer therapy and cardiovascular injury.
@en
prefLabel
Early breast cancer therapy and cardiovascular injury.
@en
P2093
P1476
Early breast cancer therapy and cardiovascular injury
@en
P2093
Lee W Jones
Mark J Haykowsky
Pamela S Douglas
P304
P356
10.1016/J.JACC.2007.06.037
P407
P577
2007-09-24T00:00:00Z